טוען...
Acute leukemia cells resistant to PI3K/mTOR inhibition display upregulation of P2RY14 expression
The PI3K/mTOR pathway is the second most frequently deregulated pathway in a majority of cancers such as breast cancer, lung cancer, and melanomas as well as leukemia. Mutations in the genes coding for receptor tyrosine kinases (RTKs) and G-protein-coupled receptors (GPCRs) are quite common in all f...
שמור ב:
| הוצא לאור ב: | Clin Epigenetics |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6010022/ https://ncbi.nlm.nih.gov/pubmed/29951132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-018-0516-x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|